Liquidia Corp (LQDA)

$12.46 -0.64 (-4.89%)
Market Cap 1.12B
Revenue (ttm) 14.00M
Net Income (ttm) -130.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -931.36%
Debt to Equity Ratio 2.83
Volume 2,302,000
Avg Vol 2,190,588
Day's Range N/A - N/A
Shares Out 85.49M
Stochastic %K 7%
Beta 0.04
Analysts Strong Sell
Price Target $30.80

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneou...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 328 4400
Fax: 919 328 4402
Address:
419 Davis Drive, Suite 100, Morrisville, United States
EatingCatPoop
EatingCatPoop Jul. 1 at 12:57 PM
$LQDA Where the buyers at? Wait until someone catches wind of how sales are going 🚀
1 · Reply
Hamboning
Hamboning Jul. 1 at 3:21 AM
$LQDA puts have and will continue to be free money. Can’t wait to see it below $12 which should happen this week 🤑
0 · Reply
nomalarkey
nomalarkey Jun. 30 at 6:54 PM
$MNKD at least it isn't dropping as much as $LQDA. Liquidia investors now know that FDA approval doesn't always bode well for a stock price just after approval and prior to any realization of sales.
0 · Reply
MikeWazowski44
MikeWazowski44 Jun. 30 at 6:34 PM
$LQDA Don’t let shorts shake you out. $20 in a year.
1 · Reply
grampslol
grampslol Jun. 29 at 11:37 AM
To review : 34 yr old $MNKD only drug approved 11 yrs ago for diabetes is a utter non-competive failure. Scrips Week ending 6/20/2025 new 400 refills 517. Joke unfunded micro pipe that BP has no interest in, can't retain employees, 800million authorized shares waiting to be converted to outstanding, massive Shelf, huge ATM , insiders getting the gold retail sh gets shafted. Nothing is coming to revive #afizzle . Pumpers lie about pennyland $MNKD to trick the naive to buy. Ignore the noise $UTHR will get crushed by $LQDA and uthr will sanofiy mnkd . #reality
3 · Reply
wwmeinc
wwmeinc Jun. 27 at 5:47 PM
$GOSS ...I am guessing the 2 new entrants are pulling in some funds...patients...well....it is a huge mkt...so only time will tell on that front but we have a very good product(that actually works to keep patients/users from needing more therapies)...so just a matter of hanging with these wild swings by all accounts...competition does or should make all mgmt teams that much more efficient or so the thinking goes :) Good trading...glta $INSM $LQDA $UTHR $MRK
0 · Reply
MikeWazowski44
MikeWazowski44 Jun. 27 at 4:47 PM
$GRAB $LQDA $GLXY Added these three today and will add dips. All 50% + possible this year.
0 · Reply
EatingCatPoop
EatingCatPoop Jun. 27 at 3:42 PM
$LQDA barely a billion mcap with a multi billion dollar drug on the market!
1 · Reply
JesusFollower
JesusFollower Jun. 27 at 2:46 PM
$LQDA
0 · Reply
EatingCatPoop
EatingCatPoop Jun. 27 at 10:57 AM
$LQDA how does someone not just try to buy this for $25/$30 right now.
1 · Reply
Latest News on LQDA
What Next For Liquidia After Launch?

Jun 30, 2025, 10:40 AM EDT - 1 day ago

What Next For Liquidia After Launch?

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 23, 2025, 4:34 PM EDT - 7 days ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Jun 2, 2025, 6:30 AM EDT - 4 weeks ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

These Analysts Boost Their Forecasts On Liquidia

May 28, 2025, 11:08 AM EDT - 4 weeks ago

These Analysts Boost Their Forecasts On Liquidia

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 28, 2025, 8:00 AM EDT - 4 weeks ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 23, 2025, 2:28 PM EDT - 5 weeks ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 12, 2025, 6:00 AM EDT - 7 weeks ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

May 10, 2025, 9:29 PM EDT - 7 weeks ago

Liquidia Corporation (LQDA) Q1 2025 Earnings Call Transcript

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 8, 2025, 6:30 AM EDT - 7 weeks ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

May 5, 2025, 4:06 PM EDT - 2 months ago

Liquidia Corporation: A Strong Buy On High Likelihood Of FDA Approval This Month

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 2, 2025, 5:28 PM EDT - 2 months ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

May 1, 2025, 8:00 AM EDT - 2 months ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Arquitos Capital's Largest Holdings  For Q1 2025

Apr 30, 2025, 9:30 AM EDT - 2 months ago

Arquitos Capital's Largest Holdings  For Q1 2025

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 3 months ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 3 months ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 28, 2025, 9:30 AM EDT - 3 months ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 11:56 AM EDT - 3 months ago

Liquidia Corporation (LQDA) Q4 2024 Earnings Call Transcript

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 19, 2025, 6:30 AM EDT - 3 months ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Mar 12, 2025, 8:00 AM EDT - 3 months ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Nov 15, 2024, 10:20 AM EST - 8 months ago

Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 2:40 PM EST - 8 months ago

Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024, 6:30 AM EST - 8 months ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 7, 2024, 10:00 AM EDT - 9 months ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Oct 2, 2024, 6:00 AM EDT - 9 months ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Oct 1, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Sep 30, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 30, 2024, 8:00 AM EDT - 9 months ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Sep 29, 2024, 11:00 AM EDT - 9 months ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Inquiry Into Liquidia Corporation

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Sep 28, 2024, 11:00 AM EDT - 9 months ago

Liquidia Corporation Is Being Investigated For Violating Securities Laws And Investors Are Invited To Contact The Schall Law Firm

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

Sep 24, 2024, 11:00 AM EDT - 10 months ago

Investors Are Invited To Help The Schall Law Firm Investigate Whether Liquidia Corporation Violated Securities Laws

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Sep 23, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Is Looking Into Liquidia Corporation For Securities Fraud And Shareholders With Losses Should Reach Out

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

Sep 21, 2024, 11:00 AM EDT - 10 months ago

Liquidia Corporation May Have Defrauded The Public And The Schall Law Firm Wants Shareholders With Losses To Reach Out

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Sep 20, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Has Launched An Inquiry Into Liquidia Corporation For Violating Securities Laws And Affected Investors Should Participate

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 10 months ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Sep 18, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Invites Investors To Join An Inquiry Into Liquidia Corporation For Violating Securities Laws

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 17, 2024, 11:00 AM EDT - 10 months ago

Liquidia Corporation Is Being Investigated For Securities Fraud And Affected Stakeholders Are Urged To Reach Out To The Schall Law Firm

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Sep 16, 2024, 9:41 AM EDT - 10 months ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

Sep 15, 2024, 11:00 AM EDT - 10 months ago

Liquidia Corporation May Have Engaged In Securities Fraud And Investors Are Urged To Join The Schall Law Firm's Investigation

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

Sep 14, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Is Inquiring Into Liquidia Corporation's Questionable Practices And Shareholders Should Reach Out

Liquidia Corporation May Have Violated Securities Regulations And The Schall Law Firm Urges Investors To Partake In An Investigation

Sep 13, 2024, 11:00 AM EDT - 10 months ago

Liquidia Corporation May Have Violated Securities Regulations And The Schall Law Firm Urges Investors To Partake In An Investigation

The Schall Law Firm Is Looking Into Whether Liquidia Corporation Engaged In Securities Fraud And Affected Shareholders Can Lend A Hand

Sep 12, 2024, 11:00 AM EDT - 10 months ago

The Schall Law Firm Is Looking Into Whether Liquidia Corporation Engaged In Securities Fraud And Affected Shareholders Can Lend A Hand

EatingCatPoop
EatingCatPoop Jul. 1 at 12:57 PM
$LQDA Where the buyers at? Wait until someone catches wind of how sales are going 🚀
1 · Reply
Hamboning
Hamboning Jul. 1 at 3:21 AM
$LQDA puts have and will continue to be free money. Can’t wait to see it below $12 which should happen this week 🤑
0 · Reply
nomalarkey
nomalarkey Jun. 30 at 6:54 PM
$MNKD at least it isn't dropping as much as $LQDA. Liquidia investors now know that FDA approval doesn't always bode well for a stock price just after approval and prior to any realization of sales.
0 · Reply
MikeWazowski44
MikeWazowski44 Jun. 30 at 6:34 PM
$LQDA Don’t let shorts shake you out. $20 in a year.
1 · Reply
grampslol
grampslol Jun. 29 at 11:37 AM
To review : 34 yr old $MNKD only drug approved 11 yrs ago for diabetes is a utter non-competive failure. Scrips Week ending 6/20/2025 new 400 refills 517. Joke unfunded micro pipe that BP has no interest in, can't retain employees, 800million authorized shares waiting to be converted to outstanding, massive Shelf, huge ATM , insiders getting the gold retail sh gets shafted. Nothing is coming to revive #afizzle . Pumpers lie about pennyland $MNKD to trick the naive to buy. Ignore the noise $UTHR will get crushed by $LQDA and uthr will sanofiy mnkd . #reality
3 · Reply
wwmeinc
wwmeinc Jun. 27 at 5:47 PM
$GOSS ...I am guessing the 2 new entrants are pulling in some funds...patients...well....it is a huge mkt...so only time will tell on that front but we have a very good product(that actually works to keep patients/users from needing more therapies)...so just a matter of hanging with these wild swings by all accounts...competition does or should make all mgmt teams that much more efficient or so the thinking goes :) Good trading...glta $INSM $LQDA $UTHR $MRK
0 · Reply
MikeWazowski44
MikeWazowski44 Jun. 27 at 4:47 PM
$GRAB $LQDA $GLXY Added these three today and will add dips. All 50% + possible this year.
0 · Reply
EatingCatPoop
EatingCatPoop Jun. 27 at 3:42 PM
$LQDA barely a billion mcap with a multi billion dollar drug on the market!
1 · Reply
JesusFollower
JesusFollower Jun. 27 at 2:46 PM
$LQDA
0 · Reply
EatingCatPoop
EatingCatPoop Jun. 27 at 10:57 AM
$LQDA how does someone not just try to buy this for $25/$30 right now.
1 · Reply
essiepaul
essiepaul Jun. 26 at 11:01 PM
$LQDA co cant stay out of the effing court room.
0 · Reply
Outslickd
Outslickd Jun. 26 at 8:49 PM
$LQDA fact of the matte is, this is deadweight until the sales start rolling in
0 · Reply
MayorofMNKD
MayorofMNKD Jun. 26 at 7:56 PM
$LQDA … three month low incoming
0 · Reply
stevemano
stevemano Jun. 26 at 6:30 PM
$LQDA garbage
0 · Reply
stevemano
stevemano Jun. 26 at 6:30 PM
$LQDA
0 · Reply
stevemano
stevemano Jun. 26 at 6:28 PM
$LQDA junk
0 · Reply
stevemano
stevemano Jun. 26 at 6:27 PM
$LQDA the big short! $3 coming!
0 · Reply
JesusFollower
JesusFollower Jun. 26 at 4:17 PM
$LQDA the tension...this one is gonna be
0 · Reply
FinABAT
FinABAT Jun. 26 at 4:08 PM
$LQDA https://x.com/oraclenyse/status/1938267191205322930?s=46&t=PEWZbEPDlfCXIpORNZ-ynQ Tim O'Connell: Sources I have in courtroom believe this trial is going very well for LQDA and all the prior art will invalidate UTHR's '327 patent as they expected
1 · Reply
OptionRunners
OptionRunners Jun. 26 at 4:07 PM
$LQDA ripping off lows https://x.com/OracleNYSE/status/1938267191205322930
0 · Reply
dayfornight99
dayfornight99 Jun. 26 at 4:02 PM
$LQDA ugggggg.
0 · Reply
MikeWazowski44
MikeWazowski44 Jun. 26 at 3:53 PM
$LQDA What’s going on here?
0 · Reply